Risk Assessment and Treatment of Low-Risk Patients with Febrile Neutropenia
Author:
Open Access
- 15 February 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 42 (4) , 533-540
Abstract
Progress has been made in the development and validation of rules that attempt ito predict a low risk (<10%) of severe infection or clinical complKeywords
This publication has 57 references indexed in Scilit:
- Inpatient Versus Outpatient Management of Low-Risk Pediatric Febrile Neutropenia: Measuring Parents' and Healthcare Professionals' PreferencesJournal of Clinical Oncology, 2004
- Management of Fever in Neutropenic Patients with Different Risks of ComplicationsClinical Infectious Diseases, 2004
- Low-risk patients with fever and neutropenia during chemotherapy: Current clinical practice patternsJournal of Clinical Oncology, 2004
- Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients: a systematic review and meta-analysis of randomized trialsJournal of Antimicrobial Chemotherapy, 2004
- Résultats d’une enquête de pratique en onco-hématologie réalisée en France en 2001La Presse Médicale, 2004
- Feasibility of outpatient management of fever in cancer patients with low-risk neutropenia: Results of a prospective randomized trialThe American Journal of Medicine, 1995
- Randomised comparison of oral ofloxacin alone with combination of parenteral antibiotics in neutropenic febrile patientsThe Lancet, 1992
- Home treatment of febrile neutropenia: An empirical oral antibiotic regimenAnnals of Oncology, 1991
- Oral ciprofloxacin therapy for infections in cancer patientsJournal of Antimicrobial Chemotherapy, 1989
- Use of Trimethoprim-Sulfamethoxazole for Treatment of Infections in Patients with CancerClinical Infectious Diseases, 1982